Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Viyash Scientific ( (IN:VIYASH) ) just unveiled an update.
Viyash Scientific Limited has announced the closure of its trading window for designated persons and their immediate relatives, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s own code of conduct. The window will remain shut from April 1, 2026, until 48 hours after the company discloses its audited financial results for the quarter and full year ended March 31, 2026, with the board meeting date for approving these results to be communicated to the exchanges later.
This move is a routine compliance measure aimed at preventing insider trading ahead of sensitive financial disclosures and underscores the company’s adherence to regulatory governance norms. For investors and other market participants, the announcement signals that audited results for the fiscal year are forthcoming, while temporarily restricting trading activity by insiders to preserve market integrity and fairness.
More about Viyash Scientific
Viyash Scientific Limited, formerly known as Sequent Scientific Limited, is an India-based listed company in the life sciences and pharmaceutical sector, with its registered office in Hyderabad, Telangana. The company’s shares are traded on BSE under the scrip code 512529 and on NSE under the symbol VIYASH, reflecting its presence in India’s public capital markets.
Average Trading Volume: 34,881
Technical Sentiment Signal: Buy
Current Market Cap: 81.72B INR
See more data about VIYASH stock on TipRanks’ Stock Analysis page.